Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Plos One|March 23, 2023
Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trialMelanie Gibson-Helm, Tania Slater, Evelyn J MacDonald, et al.
Gynecologic Oncology|June 23, 2019
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMonica Tang, Rachel L O'Connell, Frederic Amant, et al.
JMIR Research Protocols|September 14, 2023
A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover TrialBeverley Lawton, Evelyn Jane MacDonald, Francesca Storey, et al.
Journal of Primary Health Care|December 19, 2025
Opportunities to flip the narrative from burden to action for young women joining the National Cervical Screening Programme in Aotearoa New Zealand: a Kaupapa Māori qualitative exploration of experiences and knowledge of cervical screening for 18-30 year oldsTania Slater, Kendall Stevenson, Anna Adcock, et al.
Gynecologic Oncology|March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trialMonika Janda, Kristy P Robledo, Val Gebski, et al.
Gynecologic Oncology|August 20, 2021
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trialSusana N Banerjee, Monica Tang, Rachel L O'Connell, et al.
The Lancet. Oncology|July 20, 2010
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trialMonika Janda, Val Gebski, Alison Brand, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|October 9, 2020
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsyPaul A Cohen, Yee Leung, Lyndal Anderson, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Pageof 8